Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Moderna, Inc.    MRNA

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Vaccine hopes give stocks, euro and oil shot in the arm

share with twitter share with LinkedIn share with facebook
07/15/2020 | 05:19am EDT

* Stocks helped by vaccine hopes, as US-Sino tensions simmer

* Euro at four-month high ahead of recovery fund meeting

* Oil climbs before OPEC meeting

LONDON/SYDNEY, July 15 (Reuters) - World shares climbed towards a four-month high on Wednesday with the euro and oil in tow, as hopes for a coronavirus vaccine offset rising tensions between the United States and China.

Asia had a choppy session after more barbs between Beijing and Washington over Hong Kong, but near 1% gains for London , Frankfurt, Paris and Milan early on and a rise in Wall Street futures blew away any caution.

An experimental vaccine for COVID-19 produced by the U.S. company Moderna provoked safe immune responses in all 45 healthy volunteers, an early-stage study showed on Tuesday.

Uncertainty remained over how quickly an effective and rapidly available vaccine could be found, said David Miller, investment director at Quilter Cheviot Investment Management, but there was a supportive backdrop for markets.

"This is all against the background of very low interest rates," he said. "What really matters, though, is consumer confidence. I think we are all going to remain fairly wary," he said.

Hopes for progress on the European Union's 750 billion-euro COVID recovery fund this week had the euro above $1.1430 for the first time since March. It also pushed down Italy and Spain's bond market borrowing costs.

Overnight, Chinese shares fell 1.3% and Hong Kong was flat, after U.S. President Donald Trump ordered an end to Hong Kong's special status under U.S. law to punish China for its "oppressive actions" against the former British colony.

That prompted a retaliatory warning from China. Japan's Nikkei and Australia's benchmark index remained upbeat, though, finishing up 1.6% and 1.9%, respectively. E-mini futures for the S&P 500 were up 0.8%.

China's foreign ministry said Beijing would impose retaliatory sanctions against U.S. individuals and entities in response to a law targeting banks doing business with Chinese officials.

"Hong Kong affairs are purely China's internal affairs and no foreign country has the right to interfere," the ministry said.

EURO BOOST

The dollar was on the defensive, particularly against risk-sensitive currencies, following the news of progress in vaccine development.

The euro rose as high as $1.1445, its strongest since March 10 and not far off its peak so far this year of $1.1495.

The single currency has been helped by hopes the EU would agree at its summit later this week on a financing package that limited the economic damage from the pandemic.

The yen was little changed at 107.21 per dollar, off a two-week high of 106.635. The Bank of Japan kept monetary policy steady, as expected, though it warned that uncertainty over the economic outlook was "extremely high" due to various risks, including rising coronavirus infections in Tokyo.

The risk-sensitive Australian dollar pared gains to be last up 0.2% at $0.6990.

Oil prices rose after a drop in U.S. crude inventories and before a OPEC video conference on production plans later in the day. Brent crude futures were up 24 cents at $43.14 a barrel. U.S. crude futures rose 22 cents to $40.50 a barrel.

(Reporting by Marc Jones, editing by Larry King)

Stocks mentioned in the article
ChangeLast1st jan.
AUSTRALIAN DOLLAR / CANADIAN DOLLAR (AUD/CAD) 0.59% 0.95051 Delayed Quote.4.22%
AUSTRALIAN DOLLAR / JAPANESE YEN (AUD/JPY) -0.02% 76.438 Delayed Quote.0.41%
AUSTRALIAN DOLLAR / NEW ZEALAND DOLLAR (AUD/NZD) 0.33% 1.09556 Delayed Quote.4.40%
AUSTRALIAN DOLLAR / SWISS FRANC (AUD/CHF) 0.19% 0.65139 Delayed Quote.-3.65%
AUSTRALIAN DOLLAR / US DOLLAR (AUD/USD) 0.34% 0.71717 Delayed Quote.2.13%
BRITISH POUND / AUSTRALIAN DOLLAR (GBP/AUD) -0.19% 1.82485 Delayed Quote.-3.66%
BRITISH POUND / JAPANESE YEN (GBP/JPY) -0.23% 139.501 Delayed Quote.-3.30%
CANADIAN DOLLAR / JAPANESE YEN (CAD/JPY) -0.73% 80.314 Delayed Quote.-3.58%
DJ INDUSTRIAL 0.12% 27931.02 Delayed Quote.-2.25%
EURO / AUSTRALIAN DOLLAR (EUR/AUD) -0.13% 1.65045 Delayed Quote.3.03%
EURO / JAPANESE YEN (EUR/JPY) -0.16% 126.201 Delayed Quote.3.43%
JAPANESE YEN / SWISS FRANC (JPY/CHF) 0.39% 0.8526 Delayed Quote.-4.30%
LONDON BRENT OIL -0.53% 44.93 Delayed Quote.-31.35%
MODERNA, INC. 1.95% 69.15 Delayed Quote.246.78%
NASDAQ 100 -0.12% 11164.446946 Delayed Quote.28.00%
NASDAQ COMP. -0.21% 11019.300969 Delayed Quote.23.07%
NEW ZEALAND DOLLAR / JAPANESE YEN (NZD/JPY) -0.40% 69.739 Delayed Quote.-3.81%
NIKKEI 225 0.17% 23289.36 Real-time Quote.-1.72%
QUILTER PLC 0.07% 149.6 Delayed Quote.-7.17%
S&P 500 -0.02% 3372.85 Delayed Quote.4.42%
US DOLLAR / JAPANESE YEN (USD/JPY) -0.39% 106.565 Delayed Quote.-1.71%
share with twitter share with LinkedIn share with facebook
Toute l'actualité sur MODERNA, INC.
05:02pMcKesson Tapped to Distribute Coronavirus Vaccines in U.S.
DJ
03:22pCOVID-19 vaccine developer CureVac shares more than triple after U.S. debut
RE
02:09pCUREVAC IN TALKS WITH PHARMA COMPANI : Sueddeutsche
RE
02:09pTrump Administration picks McKesson for coronavirus vaccine distribution
RE
01:13pCOVID-19 vaccine developer CureVac shares more than triple after U.S. debut
RE
12:10pTrump Administration picks McKesson for coronavirus vaccine distribution
RE
12:00pVaccine makers including Moderna must hit U.S. timing goals for full payments
RE
12:00pModerna inc payments to be reduced if vaccine receives regulatory clearance a..
RE
10:14aVaccine makers including Moderna must hit U.S. timing goals for full payments
RE
10:14aNovavax, J&J Ink Covid-19 Vaccine Deals With U.K. -- Update
DJ
More news
Financials (USD)
Sales 2020 350 M - -
Net income 2020 -536 M - -
Net cash 2020 2 553 M - -
P/E ratio 2020 -48,3x
Yield 2020 -
Capitalization 27 286 M 27 286 M -
EV / Sales 2020 70,6x
EV / Sales 2021 5,03x
Nbr of Employees 975
Free-Float 80,0%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 92,40 $
Last Close Price 69,15 $
Spread / Highest target 93,8%
Spread / Average Target 33,6%
Spread / Lowest Target -16,1%
EPS Revisions
Managers
NameTitle
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
Noubar B. Afeyan Chairman
David W. Meline Chief Financial Officer
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.246.78%27 432
LONZA GROUP59.91%46 123
CELLTRION, INC.68.23%34 836
IQVIA HOLDINGS INC.5.98%31 321
SEATTLE GENETICS, INC.40.15%27 629
INCYTE CORPORATION9.44%20 606